HomeTARA • NASDAQ
add
Protara Therapeutics Inc
Previous close
$7.41
Day range
$7.28 - $7.54
Year range
$2.48 - $10.48
Market cap
284.77M USD
Avg Volume
556.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.76M | 19.71% |
Net income | -13.26M | -18.17% |
Net profit margin | — | — |
Earnings per share | -0.31 | 38.00% |
EBITDA | -14.67M | -19.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 132.67M | 62.79% |
Total assets | 144.64M | 53.72% |
Total liabilities | 12.34M | 0.37% |
Total equity | 132.29M | — |
Shares outstanding | 38.59M | — |
Price to book | 2.16 | — |
Return on assets | -24.47% | — |
Return on capital | -25.96% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -13.26M | -18.17% |
Cash from operations | -12.45M | -47.64% |
Cash from investing | -6.51M | 77.86% |
Cash from financing | 13.00K | — |
Net change in cash | -18.94M | 49.91% |
Free cash flow | -8.07M | -71.64% |
About
Founded
2006
Website
Employees
31
